What does a rash caused by Lisinopril (angiotensin-converting enzyme inhibitor) look like?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril-Induced Rash Appearance

Lisinopril-induced rash most commonly presents as angioedema, which appears as asymmetric non-pitting edema of the face, lips, tongue, and mucous membranes, and can be potentially life-threatening if not recognized and treated promptly. 1, 2

Angioedema Characteristics

  • Presents as swelling of the lips, face, tongue, pharynx, and lower face without associated urticaria or pruritus 2
  • Develops suddenly and can progress rapidly, often within hours of taking the medication 1
  • May involve the oropharynx and larynx, potentially leading to airway obstruction in severe cases 3
  • Unlike allergic reactions, typically does not present with hives, skin rashes, or itching 2
  • Can occur at any time during treatment - from first dose to years after starting lisinopril 1

Other Skin Manifestations

  • While angioedema is the most serious and recognizable skin reaction, lisinopril can occasionally cause other dermatological reactions:
    • Maculopapular rash (less common than angioedema)
    • Pruritus without visible skin changes
    • Facial flushing

Risk Factors

  • Higher incidence reported in:
    • Black patients 4
    • Women
    • Patients with history of previous angioedema (unrelated to ACE inhibitors)
    • Patients with history of allergic reactions 5

Clinical Course and Severity

  • Mild cases: Limited to lips and face without respiratory symptoms 5
  • Moderate cases: More extensive facial and oral swelling with difficulty swallowing 2
  • Severe cases: Laryngeal involvement with respiratory distress, stridor, and potential airway compromise 3
  • Fatal cases have been reported due to complete airway obstruction 3

Distinguishing Features

  • Onset: Can occur within hours to days after starting lisinopril, but may also develop after years of use 1
  • No associated urticaria (unlike allergic reactions)
  • Not dose-dependent
  • Does not typically resolve with continued use (unlike some drug rashes that improve with time)
  • Resolves within 24-48 hours after discontinuation of lisinopril and appropriate treatment 2, 5

Important Considerations

  • Angioedema is a class effect of all ACE inhibitors, not just lisinopril 5
  • The incidence is estimated between 0.1% and 0.5% of patients taking ACE inhibitors 2
  • Some evidence suggests lisinopril may have a higher incidence of angioedema compared to captopril or enalapril 5
  • Patients who experience angioedema with lisinopril should avoid all ACE inhibitors in the future 3
  • Prompt recognition is critical as progression can be rapid and potentially fatal 3

Management Approach

  • Immediate discontinuation of lisinopril 2
  • Treatment with antihistamines and corticosteroids 4
  • Close airway monitoring
  • In severe cases with respiratory compromise, epinephrine administration and potential airway management may be necessary 3

References

Research

Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death.

Iranian journal of allergy, asthma, and immunology, 2015

Research

Fatal angioedema associated with lisinopril.

The Annals of pharmacotherapy, 1992

Research

Angioedema complicating lisinopril therapy.

The Central African journal of medicine, 1992

Research

Angioedema associated with lisinopril.

The American journal of emergency medicine, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.